Related Experiment Videos
Six-antigen-matched transplants. Causes of failure
S Takemoto1, J M Cecka, D W Gjertson
1Tissue Typing Laboratory, University of California, Los Angeles 90024.
Transplantation
|May 1, 1993
Summary
HLA-matched cadaver kidney transplants show fewer immunological failures. Improving tissue typing accuracy for difficult Human Leukocyte Antigen (HLA) antigens will further reduce graft loss in kidney transplantation.
Area of Science:
- Nephrology
- Immunology
- Transplantation Science
Background:
- Cadaver kidney transplantation is a vital treatment for end-stage renal disease.
- Human Leukocyte Antigen (HLA) matching is a key factor influencing transplant success.
- Understanding causes of graft failure is crucial for improving patient outcomes.
Purpose of the Study:
- To analyze the causes of graft failure in cadaver kidney transplants.
- To compare immunological vs. non-immunological failure rates between HLA-matched and mismatched transplants.
- To investigate the impact of recipient age, sensitization, and transplant number on graft survival.
Main Methods:
- Retrospective analysis of 1386 cadaver kidney transplants from the UNOS 6-antigen match program (November 1987 - February 1992).
- Categorization of graft failures into immunological and non-immunological causes.
- Comparison of failure rates based on HLA matching status, recipient age, sensitization levels, and transplant number.
Main Results:
- One-year graft survival was 88% for HLA-matched and 78% for HLA-mismatched first cadaver transplants.
- Immunological causes accounted for 55% of HLA-mismatched failures versus 39% of HLA-matched failures.
- Immunological failure rates decreased with recipient age and increased with sensitization and for second transplants.
Conclusions:
- Phenotypically identical cadaver kidney transplants demonstrate a lower incidence of immunological graft failure.
- Improved accuracy in tissue typing for challenging HLA antigens is expected to further decrease immunological failures.
- Strategies to minimize immunological rejection remain critical in kidney transplantation, especially in younger, sensitized, or re-transplanted patients.